Prostate Cancer Research
A blog devoted to surviving prostate cancer, finding treatment options, new drug therapies and new clinical trials. We cover the very latest research.
Archives
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.
prostate cancer chemotherapy; +455 new citations
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +1986 new citations
Claiming Blog in Technorati
The Second International Meeting on Allogeneic Transplantation in Solid Tumors.
prostate cancer chemotherapy; +157 new citations
Health calendar and support groups
Prostate Cancer Screening - Serum levels of phytanic acid are associated with prostate cancer risk.
GU radiation oncologists consensus on bone loss from androgen deprivation.
Molecular biology in prostate cancer.
Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer.
prostate cancer Radiation therapy; +40 new citations
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +128 new citations
Hair Loss in Women
Prostate Cancer Screening - Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?
Prostate Cancer Prevention; +75 new citations
Prostate Cancer Genetics; +158 new citations
New molecular targets in advanced prostate cancer.
prostate cancer surgery; +260 new citations
prostate cancer Radiation therapy; +178 new citations
Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity.
prostate cancer chemotherapy; +179 new citations
Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +634 new citations
Trenton Man Shares Cancer Story
Prostate Cancer Screening - Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
Some sociodemographic and diagnostic characteristics of military patients treated in the Department of Medical Oncology, G lhane Military Medical Academy.
Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers.
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial.
prostate cancer Radiation therapy; +28 new citations
[Cancer immunotherapy--current status]
Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes.
A tumour stem cell hypothesis for the origins of prostate cancer.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +215 new citations
New Eloxatin(R) and Taxotere(R) Data in Several Tumor Types to Be ...
Prostate Cancer Screening - Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases.
The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy.
Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer.
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
prostate cancer Radiation therapy; +31 new citations
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.
Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model.
Books : Lonely Planet Healthy Travel Africa (Lonely Planet Healthy
Prostate Cancer Screening - Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
France to pilot testing for prostate cancer.
Expression and implication of hypoxia inducible factor-1alpha in prostate neoplasm.
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Robotic prostatectomy: is it the future?
Prognostic value of PSA nadir < or =4 ng/mL within 4 months of high-dose radiotherapy for locally advanced prostate cancer.
Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: Implications for targeting to tumor vasculature.
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +259 new citations
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
[Clinicopathological study of incidental cancer prostate in patients undergoing surgery for symptomatic diagnosis of BPH]
Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy.
[Neoplastic pathology of the prostate: perspectives]
Radiation therapy combined with hormone therapy for prostate cancer.
Is dehydroepiandrosterone a hormone?
Durbin joins call to block employers option bill
Prostate Cancer Screening - Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases.
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
Overexpression of ecto-protein kinases in prostasomes of metastatic cell origin.
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.
prostate cancer Radiation therapy; +40 new citations
[Neoplastic pathology of the prostate: perspectives]
Why herbs?
Prostate Cancer Screening - Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells.
Role of dietary modification and vitamins in prostate cancer.
Tuesday, April 18 12 p.m. - 1 p.m. EST
Prostate Cancer Screening - Re: individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Being screened for prostate cancer: a simple blood test or a commitment to treatment?
Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.
STEAP, a prostate tumor antigen, is a target of human CD8(+) T cells.
Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
Is dehydroepiandrosterone a hormone?
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
Chamomile Tea And Lotion Causing Internal Bleeding In Patient On Anti-coagulant Medication
Prostate Cancer Screening - Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
Anti-emetic therapy: updating urological cancer-care providers.
RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
prostate cancer surgery; +55 new citations
prostate cancer Radiation therapy; +49 new citations
STEAP, a prostate tumor antigen, is a target of human CD8(+) T cells.
Intra-operative prostate examination: predictive value and effect on margin status.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +184 new citations
Chili's heat might kill prostate cancer cells, study says
Prostate Cancer Screening - Re: individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.
Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population.
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.
Robot-assisted needle placement in open-MRI: system architecture, integration and validation.
Integral radiation dose to normal structures with conformal external beam radiation.
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.
Multi-resistant Escherichia coli sepsis following transrectal ultrasound-guided prostate biopsy.
High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen.
Hand-assisted laparoscopic cystoprostatectomy and urinary diversion.
Profiling alternatively spliced mRNA isoforms for prostate cancer classification.
Book Description:
Prostate Cancer Screening - HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
Prostate cancer update: 2005.
MCM7 amplification and overexpression are associated with prostate cancer progression.
[Construction and immunological study of recombinant hBD-2/PSMA chimeric protein eukaryotic expressive plasmid]
prostate cancer surgery; +88 new citations
prostate cancer Radiation therapy; +50 new citations
Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Downregulation of CK2 induces apoptosis in cancer cells--a potential approach to cancer therapy.
Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +73 new citations
Proudly searching ONLY South Africa
Prostate Cancer Screening - The influence of extent of surgical margin positivity on prostate specific antigen recurrence.
Hormone refractory prostate cancer (HRPC): present and future approaches of therapy.
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +165 new citations
Chili's Heat Kills Prostate Cancer Cells
Prostate Cancer Screening - Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells.
Maintaining bone health in patients with prostate cancer.
Gene delivery and gene therapy of prostate cancer.
[Construction and immunological study of recombinant hBD-2/PSMA chimeric protein eukaryotic expressive plasmid]
Maintaining bone health in patients with prostate cancer.
Patterns of practice in the management of prostate cancer: results from multidisciplinary surveys of clinicians in Australia and New Zealand in 1995 and 2000.
A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells.
Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.
Factors contributing to the racial differences in prostate cancer mortality.
A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
New research bruises reputations of many nutrition supplements
Prostate Cancer Screening - Intra-operative prostate examination: predictive value and effect on margin status.
Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic.
The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes.
[Construction and immunological study of recombinant hBD-2/PSMA chimeric protein eukaryotic expressive plasmid]
Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study).
Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center.
[Prostate cancer gene therapy]
Management strategies for locally advanced prostate cancer.
Promise for prostatitis?
Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center.
New research bruises reputations of many nutrition supplements
Prostate Cancer Screening - Sexual, psychological and dyadic qualities of the prostate cancer 'couple'.
Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic.
Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism.
[Construction and immunological study of recombinant hBD-2/PSMA chimeric protein eukaryotic expressive plasmid]
[Volume and health outcomes: an overview of systematic reviews]
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
Antibody-based therapeutics: focus on prostate cancer.
Thermally induced injury and heat-shock protein expression in cells and tissues.
Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
Delayed Prostate Cancer Surgery Poses No Increased Risk for Some ...
Prostate Cancer Screening - Obesity and capsular incision at the time of open retropubic radical prostatectomy.
Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans.
[Construction and immunological study of recombinant hBD-2/PSMA chimeric protein eukaryotic expressive plasmid]
prostate cancer surgery; +83 new citations
prostate cancer Radiation therapy; +44 new citations
Immunotherapy for prostate cancer.
prostate cancer chemotherapy; +64 new citations
Factors contributing to the racial differences in prostate cancer mortality.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +262 new citations
Androgen Deprivation Therapy Does Not Keep Localized Prostate Cancer From Spreading, New Study Says
Prostate Cancer Screening - Intra-operative prostate examination: predictive value and effect on margin status.
Maspin alters the carcinoma proteome.
Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.
Technology Insight: vaccine therapy for prostate cancer.
[Results of a series of transrectal ultrasound guided biopsy of the prostate in 6000 patients. Part II: PSA derived parameters]
A comparison of three-field and four-field techniques in different clinical target volumes in prostate cancer irradiation using dose volume histograms: a prospective three-dimensional analysis.
Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek).
In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?
In King's death, a lesson in ovarian cancer's deadliness
Prostate Cancer Screening - Urinary estrogen metabolites, prostate specific antigen, and body mass index among African-American men in South Carolina.
Prostate Cancer Prevention Through Pomegranate Fruit.
Under pressure: stromal fibroblasts change their ways.
Technology Insight: vaccine therapy for prostate cancer.
[Advancement of treatment for prostate cancer.]
[Advancement of treatment for prostate cancer.]
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
Development and evaluation of a prostate sexual rehabilitation clinic: a pilot project.
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
Ovarian Cancer's Deadliness
Prostate Cancer Screening - Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
Do the Benefits of Finasteride Outweigh the Risks in the Prostate Cancer Prevention Trial?
Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
Technology Insight: vaccine therapy for prostate cancer.
Robotic extraperitoneal radical prostatectomy: an alternative approach.
Rising prostate-specific antigen after primary prostate cancer therapy.
Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Intra-operative prostate examination: predictive value and effect on margin status.
Advanced refractory prostate cancer: new treatment trial.
Prostate Cancer Screening - Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the prostate cancer awareness week (PCAW).
HER-2/neu peptide vaccine for the prevention of prostate cancer recurrence.
[Expression of Trp-p8 in prostate and its significant]
Technology Insight: vaccine therapy for prostate cancer.
Salvage surgery in prostate cancer: assessment of rectal wall invasion.
Is pretreatment PSA velocity associated with prostate-cancer-specific mortality rate after radiotherapy?
Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.
Promising chemotherapy regimen for hormone-refractory prostate cancer.
Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy.
An educational workshop on the early detection of prostate cancer--a before-after evaluation.
Ovarian Cancer's Deadliness
Prostate Cancer Screening - Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevation.
Do the Benefits of Finasteride Outweigh the Risks in the Prostate Cancer Prevention Trial?
[Expression of Trp-p8 in prostate and its significant]
Technology Insight: vaccine therapy for prostate cancer.
Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study.
Locally advanced prostate cancer treated with radiotherapy and androgen deprivation.
Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis.
[Prognostic factors for PSA relapse of prostate cancer after endocrine therapy]
Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer.
Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting.
Start-up hopes to challenge Google
Prostate Cancer Screening - A prospective study of physical activity and incident and fatal prostate cancer Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC, Department of Nutrition, Harvard School of Public Health, Boston, MA.
Radiation therapy for prostate cancer and erectile (dys)function: the role of imaging.
E-cadherin gene 3'-UTR C/T polymorphism is associated with prostate cancer.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
Advances in radiotherapy for prostate cancer.
Current drug therapy for prostate cancer: an overview.
Changes in tissue prostatic acidic phosphatase during endocrine treatment of patients with prostatic carcinoma.
Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
Winning the Battle
Prostate Cancer Screening - Serum levels of phytanic acid are associated with prostate cancer risk.
Radiation therapy for prostate cancer and erectile (dys)function: the role of imaging.
A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
Advances in radiotherapy for prostate cancer.
Current drug therapy for prostate cancer: an overview.
Annual cancer deaths fall for first time in 70 years
Prostate Cancer Screening - Salvage radiotherapy for biochemical recurrence after radical prostatectomy.
Radiation therapy for prostate cancer and erectile (dys)function: the role of imaging.
Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
E-cadherin gene 3'-UTR C/T polymorphism is associated with prostate cancer.
Large deformation three-dimensional image registration in image-guided radiation therapy.
Current drug therapy for prostate cancer: an overview.
Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen-independent prostate cancer.
Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.
Annual cancer deaths fall for first time in 70 years
Prostate Cancer Screening - Incidence and management of gynecomastia in men treated for prostate cancer.
[Prostate cancer prevention]
Optimizing prostate cancer treatment by combining local radiation therapy with systemic vaccination.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Molecular alterations in primary prostate cancer after androgen ablation therapy.
Radiation sensitivity of human carcinoma cells transfected with small interfering RNA targeted against cyclooxygenase-2.
Current drug therapy for prostate cancer: an overview.
Docetaxel in hormone-refractory metastatic prostate cancer.
Acute renal failure secondary to imatinib mesylate treatment in prostate cancer.
Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.
Is Cancer becoming an epidemic?
Prostate Cancer Screening - The need to reduce patient discomfort during transrectal ultrasonography-guided prostate biopsy: what do we know?
Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?
Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Ablation of stage T1/T2 prostate cancer with permanent interstitial temperature self-regulating rods.
Influence of number of CAG repeats on local control in the RTOG 86-10 protocol.
Current drug therapy for prostate cancer: an overview.
Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone.
Long-term clinical outcomes of 420 consecutive prostate cancer patients in a single institute.
Laparoscopic surgery for melanoma metastases to the adrenal gland.
Controlling Your Impulses After Parkinson's Treatment
Prostate Cancer Screening - Urinary estrogen metabolites, prostate specific antigen, and body mass index among African-American men in South Carolina.
A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis.
A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Transrectal ultrasound guided biopsy for detecting early prostate cancer: An Indian experience.
Integral radiation dose to normal structures with conformal external beam radiation.
Current drug therapy for prostate cancer: an overview.
Hormone refractory prostate cancer: Management and advances.
Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the prostate cancer awareness week (PCAW).
Cancer map patterns are they random or not?
Prostate Cancer Screening - Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
Red wine may influence prostate cancer risk.
Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Complications following combined transrectal ultrasound-guided prostate needle biopsies and transurethral resection of the prostate.
[Evaluation of Setup Error and Adequate Setup Margins in Patients with Prostate Cancer Treated by IMRT and Fixed in the Prone Position Using a Set of Immobilization Devices.]
Current drug therapy for prostate cancer: an overview.
Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells.
Positive Inter-Regulation between beta-Catenin/T Cell Factor-4 Signaling and Endothelin-1 Signaling Potentiates Proliferation and Survival of Prostate Cancer Cells.
[Nutrition and pharmacological treatment for prevention of prostate cancer]
Prostate Cancer Screening - Hand-assisted laparoscopic cystoprostatectomy and urinary diversion.
Selecting patients with pretreatment postvoid residual urine volume less than 100 mL may favorably influence brachytherapy-related urinary morbidity.
Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Recent trends in surgical treatment of localized prostate cancer.
Oblique needle segmentation and tracking for 3D TRUS guided prostate brachytherapy.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
Acute renal failure secondary to imatinib mesylate treatment in prostate cancer.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +90 new citations
Alternative therapy common in prostate cancer
Prostate Cancer Screening - Germline mutations of the MSR1 gene in prostate cancer families from Germany.
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells.
Biochemical nature and mapping of PSMA epitopes recognized by human antibodies induced after immunization with gene-based vaccines.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
High dose brachytherapy (real time) in patients with intermediate- or high-risk prostate cancer: technical description and preliminary experience.
Optimization of intensity-modulated radiation therapy with biological objectives.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +90 new citations
Prostate Cancer Screening - Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy.
Alpha-linolenic acid: a gift from the land?
Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
Managed care market share and primary treatment for cancer.
Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.
Cloning and sequencing of the cynomolgus monkey prostate specific antigen cDNA.
A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +90 new citations
Prostate Cancer Screening - Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevation.
Polo-like kinase (Plk) 1 as a target for prostate cancer management.
Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Evaluation of lipophilins as determinants of tumor cell response to estramustine.
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Chemotherapy with Docetaxel/Prednisone for Localized, High-Risk Prostate Cance
Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
Side-effects of treatments for locally advanced prostate cancer.
The mineral selenium proves itself as powerful anti-cancer medicine
Prostate Cancer Screening - Observed effect of age and body mass index on total and complexed PSA: analysis from a National Screening Program.
Changes in bone mineral density in patients with prostate cancer treated with androgen deprivation therapy.
Polo-like kinase (Plk) 1 as a target for prostate cancer management.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer.
L14: erectile dysfunction after radiotherapy for prostate cancer.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway.
Pre-Treatment Nomogram for Disease-Specific Survival of Patients with Chemotherapy-Naive Androgen Independent Prostate Cancer.
Dr. Manny: Expert Advice on Prostate Cancer
Prostate Cancer Screening - Intra-operative prostate examination: predictive value and effect on margin status.
Combined Inhibitory Effects of Curcumin and Phenethyl Isothiocyanate on the Growth of Human PC-3 Prostate Xenografts in Immunodeficient Mice.
Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data.
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
RTOG study shows improved survival for prostate cancer patients given adjuvant goserelin.
Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
Histopathological outcome in 167 patients operated on with radical retropubic prostatectomy.
Health Calendar
Prostate Cancer Screening - The influence of extent of surgical margin positivity on prostate specific antigen recurrence.
Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis.
Identification of a positive Cis-element upstream of human NKX3.1 gene.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Recent neuroanatomical studies on the neurovascular bundle of the prostate and cavernosal nerves: clinical reflections on radical prostatectomy.
The Actual Value of the Surgical Margin Status as a Predictor of Disease Progression in Men with Early Prostate Cancer.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Is dehydroepiandrosterone a hormone?
Does docetaxel plus prednisone prolong the survival of men with metastatic hormone-refractory prostate cancer?
Down-regulation of cyclooxygenase-2 and telomerase activity by beta-lapachone in human prostate carcinoma cells.
Medical News Story
Prostate Cancer Screening - Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.
Report from London.
The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
A rare prostatic tumor in a 48-year-old man.
[Delay to radiotherapy: a study of three tumour sites]
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
Acute renal failure secondary to imatinib mesylate treatment in prostate cancer.
Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy.
Real Stories: We Should All Be Dead
Prostate Cancer Screening - Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project.
Prevention of cancer in the older person.
[Advances on inhibin genes.]
Antiandrogen and vaccine therapy for hormone-refractory prostate cancer.
Use of a temporary plastic stent to facilitate the placement of multiple self-expanding metal stents in malignant biliary hilar strictures.
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients.
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy.
Prostate Cancer Screening - Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.
[Screening of cancer of the most frequent localizations]
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers.
Therapeutic vaccines for prostate cancer: a review of clinical data.
IGF-II Serum Levels Increase Discrimination Between Benign Prostatic Hyperplasia and Prostate Cancer and Improve the Predictive Value of PSA in Clinical Staging.
A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer.
A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer.
Prostate Cancer Screening - Revisiting my personal decision about prostate-specific antigen testing in 2005.
Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded.
(99m)Tc-EC-guanine: synthesis, biodistribution, and tumor imaging in animals.
Therapeutic vaccines for prostate cancer: a review of clinical data.
Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
[Advances in brachytherapy]
Combined antiangiogenic and immune therapy of prostate cancer.
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.
Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +120 new citations
Real Stories: We Should All Be Dead
Prostate Cancer Screening - The influence of extent of surgical margin positivity on prostate specific antigen recurrence.
Prevention of cancer in the older person.
Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded.
[Construction and immunological study of recombinant hBD-2/PSMA chimeric protein eukaryotic expressive plasmid]
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.
[Advances in brachytherapy]
Combined antiangiogenic and immune therapy of prostate cancer.
[Indications of the association of radiotherapy and hormonal treatment in prostate cancer]
Salvage radiotherapy for biochemical recurrence after radical prostatectomy.
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +120 new citations
MedSpa and Deli Offer Tips for Holiday Fitness -- and Indulgence
Prostate Cancer Screening - Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.
The protective effects of green tea in prostate cancer.
[Identification of tumor antigens: strategies and perspectives]
[Subcapsular orchiectomy in the treatment of prostate cancer: results]
Prostate Cancer Screening - Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA.
Emerging minimally invasive techniques for treating localized prostate cancer.
prostate cancer Radiation therapy; +24 new citations
Tumor escape mechanisms in prostate cancer.
Prostate cancer epidemiology. Related Articles Prostate cancer epidemiology. Front Biosci.
Critical function for ADAM9 in mouse prostate cancer. Related Articles
National cooperative group trials. Related Articles National cooperative group trials.
Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy.
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical
Tumor escape mechanisms in prostate cancer. Related Articles Tumor escape
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate
Can docetaxel plus estramustine prolong survival of men with metastatic
Targeting apoptosis in prostate cancer: focus on caspases and inhibitors
Vaccine therapy for a patient with androgen-insensitive prostate cancer without
FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent
Gene therapy for prostate cancer: Current strategies and new cell-based
Targeted elimination of prostate cancer by genetically directed human T
IC Wales -
Prostate Cancer Screening - Intra-operative prostate examination: predictive value and effect on margin status.
Prospective studies of dairy product and calcium intakes and prostate
A candidate gene approach to searching for low-penetrance breast and
Immune-based therapies for prostate cancer. Related Articles Immune-based therapies for
Stromal expression of connective tissue growth factor promotes angiogenesis and
Retrospective evaluation of bone pain palliation after samarium-153-EDTMP therapy. Related
Targeted elimination of prostate cancer by genetically directed human T
prostate cancer chemotherapy; +70 new citations 70 new PubMed citations
Multidisciplinary treatment of synchronous primary rectal and prostate cancers. Related
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate
Interim Analysis of Phase III Study Shows TAXOTERE(R)-Based Regimens With HERCEPTIN(R) Significantly Improved Disease
Prostate Cancer Screening - Androgen deprivation use with external beam radiation for prostate cancer:
Sexual function-preserving cystectomy. Related Articles Sexual function-preserving cystectomy. Urology. 2005
The cross talk between protein kinase A- and RhoA-mediated signaling
[Construction and immunological study of recombinant hBD-2/PSMA chimeric protein eukaryotic
Prostate cancer cash cut fears
Prostate Cancer Screening - Phase II trial of tesmilifene plus mitoxantrone and prednisone for
Karyometry in the early detection and chemoprevention of intraepithelial lesions.
Radiosensitivity detected by the micronucleus test is not generally increased
Human CTLs to wild-type and enhanced epitopes of a novel
prostate cancer surgery; +102 new citations 102 new PubMed citations
prostate cancer Radiation therapy; +48 new citations 48 new PubMed
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based
Prostate cancer cash cut fears
Prostate Cancer Screening - Deregulated expression of prostate apoptosis response gene-4 in less differentiated
Selenium in cancer prevention: a review of the evidence and
Steroid hormones stimulate human prostate cancer progression and metastasis. Related
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine:
[Update of the treatment of advanced prostate cancer and management
Antiandrogenic therapy can cause coronary arterial disease. Related Articles Antiandrogenic
Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy
The Health of Older-Adult, Long-term Cancer Survivors. Related Articles The
Can docetaxel plus estramustine prolong survival of men with metastatic
Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the
Prostate Cancer Screening - Vascular endothelial growth factor expression in untreated and androgen-deprived patients
Minority recruitment to the Selenium and Vitamin E Cancer Prevention
Steroid hormones stimulate human prostate cancer progression and metastasis. Related
Prostate Cancer Screening - Estimation of treatment benefits when PSA screening for prostate cancer
Minority recruitment to the Selenium and Vitamin E Cancer Prevention
Steroid hormones stimulate human prostate cancer progression and metastasis. Related
[Identification of tumor antigens: strategies and perspectives] Related Articles [Identification
The potential of proton beam radiation therapy in prostate cancer,
Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor
Prostate cancer cash cut fears
Prostate Cancer Screening - Estimation of treatment benefits when PSA screening for prostate cancer
Selenium in cancer prevention: a review of the evidence and
Steroid hormones stimulate human prostate cancer progression and metastasis. Related
Vaccine therapy for a patient with androgen-insensitive prostate cancer without
Cytokinetics Announces Presentation of Ispinesib Data at San Antonio Breast Cancer Symposium
Prostate Cancer Screening - Lidocaine suppositories for prostate biopsy. Related Articles Lidocaine suppositories for
Minority recruitment to the Selenium and Vitamin E Cancer Prevention
Steroid hormones stimulate human prostate cancer progression and metastasis. Related
National cooperative group trials. Related Articles National cooperative group trials.
[Update of the treatment of advanced prostate cancer and management
Sexual function after external-beam radiotherapy for prostate cancer: What do
Tissue-specificity of prostate specific antigens: Comparative analysis of transcript levels
Sexual function after external-beam radiotherapy for prostate cancer: What do
High-affinity Near-infrared Fluorescent Small-molecule Contrast Agents for in vivo Imaging
Open Retropubic Nerve-Sparing Radical Prostatectomy. Related Articles Open Retropubic Nerve-Sparing
Highlights from the 41st Annual Meeting of the American Society
Prostate Cancer Screening - Clinical staging of prostate cancer: a computer-simulated study of transperineal
Antiandrogen and vaccine therapy for hormone-refractory prostate cancer. Related Articles
Prognosis improving for area hospitals
Prostate Cancer Screening - Germline mutations of the MSR1 gene in prostate cancer families
Selenium in cancer prevention: a review of the evidence and
Use of tissue recombination to predict phenotypes of transgenic mouse
Vaccine therapy for a patient with androgen-insensitive prostate cancer without
Elevated expression of angiogenin in prostate cancer and its precursors.
Spinal leptomeningeal metastases from prostate cancer. Spinal leptomeningeal metastases from
Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies. Related
Ixabepilone (Epothilone B Analogue BMS-247550) Is Active in Chemotherapy-Naive Patients
Effects of 2,4-D and DCP on the DHT-induced androgenic action
Elevated expression of angiogenin in prostate cancer and its precursors.
Zoledronic acid is effective in preventing and delaying skeletal events
Phase II Feasibility Study of High-Dose Radiotherapy for Prostate Cancer
Recognition of prostate and breast tumor cells by helper T
Ixabepilone (Epothilone B Analogue BMS-247550) Is Active in Chemotherapy-Naive Patients
Renal Safety and Efficacy of i.v. Bisphosphonates in Patients with
Prostate Cancer Screening - Phase II trial of tesmilifene plus mitoxantrone and prednisone for
Cancer of the prostate. Related Articles Cancer of the prostate.
HEALTH CALENDAR: HEALTH CALENDAR
Prostate Cancer Screening - Link between exercise and lower risk for prostate cancer found.
[Therapy of hormone-refractory prostate cancer.] Related Articles [Therapy of hormone-refractory
Effects of 2,4-D and DCP on the DHT-induced androgenic action
Therapeutic vaccines for prostate cancer: a review of clinical data.
Epidural spinal cord compression. Related Articles Epidural spinal cord compression.
Epidural spinal cord compression. Related Articles Epidural spinal cord compression.
[Expression of prostate stem cell antigen (PSCA) and selection of
[Therapy of hormone-refractory prostate cancer.] Related Articles [Therapy of hormone-refractory
[Therapy of hormone-refractory prostate cancer.] Related Articles [Therapy of hormone-refractory
Recycled Or Revamped Therapeutics Find Novel Anti-Cancer Applications
Prostate Cancer Screening - Effects of 2,4-D and DCP on the DHT-induced androgenic action
[Therapy of hormone-refractory prostate cancer.] Related Articles [Therapy of hormone-refractory
Health motivation and emotional vigilance in genetic testing for prostate
Human CTLs to wild-type and enhanced epitopes of a novel
Epidural spinal cord compression. Related Articles Epidural spinal cord compression.
Cancer of the prostate. Related Articles Cancer of the prostate.
Prostate cancer vaccine
Prostate Cancer Screening - Satraplatin in the treatment of hormone-refractory prostate cancer. Related Articles
Operating characteristics of prostate-specific antigen in men with an initial
Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevation. Related Articles
Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate
CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate
Monotherapeutic brachytherapy for clinically organ-confined prostate cancer. Related Articles Monotherapeutic
Advanced prostate cancer: the future. Related Articles Advanced prostate cancer:
[Prostate cancer chemotherapy, myth or reality?] Related Articles [Prostate cancer
Non-genomic effects of the androgen receptor and Vitamin D agonist
20-year outcomes following conservative management of clinically localized prostate cancer
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing
[In Process Citation] Related Articles [In Process Citation] Ann Urol
Prostate Cancer Screening - Role of SRC-1 in the promotion of prostate cancer cell
Effect of methylprednisolone on return of sexual function after nerve-sparing
The need to reduce patient discomfort during transrectal ultrasonography-guided prostate
Prostate Cancer Screening - [Prostate neoplasms--tumor grading and magnetic resonance spectroscopy] Related Articles [Prostate
[The study landscape for prostate cancer.] Related Articles [The study
Prostate cancer cells promote osteoblastic bone metastases through Wnts. Related
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody
CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate
[In Process Citation] Related Articles [In Process Citation] Ann Urol
Prostate Cancer Screening - Role of SRC-1 in the promotion of prostate cancer cell
Differential expression of steroid receptors in prostate tissues before and
Prostate Cancer Screening - Prostate Cancer Screening; +56 new citations 56 new PubMed citations
[In Process Citation] Related Articles [In Process Citation] Ann Urol
Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of
Corticosteroid-Induced Chemotherapy Resistance in Urological Cancers. Related Articles Corticosteroid-Induced Chemotherapy
Novel therapeutic approaches to advanced prostate cancer. Related Articles Novel
Non-genomic effects of the androgen receptor and Vitamin D agonist
prostate cancer; +81 new citations 81 new PubMed citations were
prostate cancer treatment; +70 new citations 70 new PubMed citations
[The study landscape for prostate cancer.] Related Articles [The study
prostate cancer treatment; +70 new citations 70 new PubMed citations
Corticosteroid-Induced Chemotherapy Resistance in Urological Cancers. Related Articles Corticosteroid-Induced Chemotherapy
Advanced prostate cancer: the future. Related Articles Advanced prostate cancer:
Calcitonin increases invasiveness of prostate cancer cells: role for cyclic
Differential expression of steroid receptors in prostate tissues before and
Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired
Prostate Cancer Screening - Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated
Human CTLs to wild-type and enhanced epitopes of a novel
Does androgen deprivation improve treatment outcomes in patients with low-risk
Giveaway samples year's self-help books
Prostate Cancer Screening - Prostate cancer among African-American males: understanding the current issues. Related
Breast-feeding and cancer: the Boyd Orr cohort and a systematic
Leptin gene polymorphisms and their phenotypic associations. Related Articles Leptin
Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate
[Budd-Chiari syndrome in a patient with paroxysmal nocturnal haemoglobinuria] Related
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to
Tissue-specificity of prostate specific antigens: Comparative analysis of transcript levels
Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver
Use of Complementary Therapies Among Breast and Prostate Cancer Patients
A MULTICENTER CLINICAL TRIAL ON THE USE OF (-5, -7)
Search
Search this blog:
Categories
Alternative Prostate Cancer Treatments
Prostate Cancer Genetics
Prostate Cancer Prevention
Prostate Cancer Screening
Prostate Cancer Treatment
Chemotherapy
Immunotherapy
Radiation therapy
Surgery
Vaccine therapy
Archives
August 2007
February 2007
September 2006
August 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
Recent Posts
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.
prostate cancer chemotherapy; +455 new citations
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +1986 new citations
Claiming Blog in Technorati
The Second International Meeting on Allogeneic Transplantation in Solid Tumors.
prostate cancer chemotherapy; +157 new citations
Health calendar and support groups
Prostate Cancer Screening - Serum levels of phytanic acid are associated with prostate cancer risk.
GU radiation oncologists consensus on bone loss from androgen deprivation.
Subscribe to this blog's feed
[
What is this?
]
Powered by
Movable Type 3.34